IGC Pharma, Inc. IGS1.F Stock
IGC Pharma, Inc. Price Chart
IGC Pharma, Inc. IGS1.F Financial and Trading Overview
| IGC Pharma, Inc. stock price | 0.48 EUR |
| Previous Close | 0.26 EUR |
| Open | 0.26 EUR |
| Bid | 0.25 EUR x 1000000 |
| Ask | 0.3 EUR x 1000000 |
| Day's Range | 0.26 - 0.26 EUR |
| 52 Week Range | 0.25 - 0.59 EUR |
| Volume | 3K EUR |
| Avg. Volume | 166 EUR |
| Market Cap | 14.76M EUR |
| Beta (5Y Monthly) | 3.339436 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.24 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IGS1.F Valuation Measures
| Enterprise Value | 9.28M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 17.02316 |
| Price/Book (mrq) | 0.7536232 |
| Enterprise Value/Revenue | 10.706 |
| Enterprise Value/EBITDA | -1.167 |
Trading Information
IGC Pharma, Inc. Stock Price History
| Beta (5Y Monthly) | 3.339436 |
| 52-Week Change | -52.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.59 EUR |
| 52 Week Low | 0.25 EUR |
| 50-Day Moving Average | 0.28 EUR |
| 200-Day Moving Average | 0.36 EUR |
IGS1.F Share Statistics
| Avg. Volume (3 month) | 166 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 53.08M |
| Float | 47.96M |
| Short Ratio | N/A |
| % Held by Insiders | 17.12% |
| % Held by Institutions | 5.55% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -994.57% |
| Gross Margin | 51.55% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -20.98% |
| Return on Equity (ttm) | -58.49% |
Income Statement
| Revenue (ttm) | 867K EUR |
| Revenue Per Share (ttm) | 0.02 EUR |
| Quarterly Revenue Growth (yoy) | 133.80% |
| Gross Profit (ttm) | 194K EUR |
| EBITDA | -7954000 EUR |
| Net Income Avi to Common (ttm) | -13979000 EUR |
| Diluted EPS (ttm) | -0.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.03M EUR |
| Total Cash Per Share (mrq) | 0.1 EUR |
| Total Debt (mrq) | 515K EUR |
| Total Debt/Equity (mrq) | 2.81 EUR |
| Current Ratio (mrq) | 6.898 |
| Book Value Per Share (mrq) | 0.345 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6417000 EUR |
| Levered Free Cash Flow (ttm) | 1.01M EUR |
Profile of IGC Pharma, Inc.
| Country | Germany |
| State | MD |
| City | Potomac |
| Address | 10224 Falls Road |
| ZIP | 20854 |
| Phone | 301 983 0998 |
| Website | https://www.igcinc.us |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 52 |
IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development. It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Q&A For IGC Pharma, Inc. Stock
What is a current IGS1.F stock price?
IGC Pharma, Inc. IGS1.F stock price today per share is 0.48 EUR.
How to purchase IGC Pharma, Inc. stock?
You can buy IGS1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IGC Pharma, Inc.?
The stock symbol or ticker of IGC Pharma, Inc. is IGS1.F.
Which industry does the IGC Pharma, Inc. company belong to?
The IGC Pharma, Inc. industry is Biotechnology.
How many shares does IGC Pharma, Inc. have in circulation?
The max supply of IGC Pharma, Inc. shares is 66.06M.
What is IGC Pharma, Inc. Price to Earnings Ratio (PE Ratio)?
IGC Pharma, Inc. PE Ratio is now.
What was IGC Pharma, Inc. earnings per share over the trailing 12 months (TTM)?
IGC Pharma, Inc. EPS is -0.24 EUR over the trailing 12 months.
Which sector does the IGC Pharma, Inc. company belong to?
The IGC Pharma, Inc. sector is Healthcare.